Rate My Professor Bryony Ross

Her research has produced numerous publications advancing transfusion practices and haematology. Key works include 'Serological screening for cytomegalovirus in a leucodepleted blood supply: A systematic review' (2026), 'Iron optimisation in pregnancy: a Haematology in Obstetric and Women's Health Collaborative consensus statement' (2025), 'The incidence of donor white blood cell survival (transfusion-associated microchimerism) in Australian pediatric patients' (2024), 'Iron deficiency in women: clearing the rust of silence' (The Lancet Haematology, 2022), 'Every one counts: A retrospective cohort study examining the safety of extending pre-transfusion compatibility testing from 72 hours to 7 days in hematology patients receiving red blood cell transfusions' (2023), 'Transfusion-associated circulatory overload in ambulatory patients' (2019), 'Zeroing in on red blood cell unit expiry' (2017), and 'Development of novel PP2A activators for use in the treatment of acute myeloid leukaemia' (2016). Additional publications address viscoelastic haemostatic assays in paediatric acute traumatic coagulopathy, adherence to antenatal haemoglobinopathy screening, and embedding best transfusion practices in neonatal intensive care. Ross collaborates with researchers such as Anoop K. Enjeti, Matt Dun, and Nikki Verrills on projects including an NHMRC Project Grant. Her contributions enhance transfusion safety, reduce wastage, and improve outcomes in obstetric, neonatal, and paediatric haematology.